Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bristol/Celgene Made Perfect Sense, But Doesn’t Promise Big M&A Year, EY Says
Jan 08 2019
•
By
Joseph Haas
EY Global Life Sciences Transactions Leader Peter Behner
More from Strategy
More from Business